Leveraging CAR macrophages targeting c-Met for precision immunotherapy in pancreatic cancer: insights from single-cell multi-omics
Abstract Background Pancreatic cancer is known for its poor prognosis and resistance to conventional therapies, largely due to the presence of cancer stem cells (CSCs) and aggressive angiogenesis. Effectively targeting these CSCs and associated angiogenic pathways is crucial for effective treatment....
Saved in:
| Main Authors: | Lingyu Hu, Xiaoguang Wang, Zhengwei Song, Fei Chen, Bin Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10020-024-00996-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Innovative Approaches in the Treatment of Pancreatic Cancer: The Role of CAR T-Cell Therapy
by: Jakub Kuźniar, et al.
Published: (2025-05-01) -
Efficacy of MET-targeting CAR T cells against glioblastoma patient-derived xenograft models
by: Anna Qin, et al.
Published: (2025-04-01) -
From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy
by: Yuting Gong, et al.
Published: (2025-05-01) -
CAR Beyond αβ T Cells: Unleashing NK Cells, Macrophages, and γδ T Lymphocytes Against Solid Tumors
by: Yunjia Xian, et al.
Published: (2025-06-01) -
CAR-exosomes derived from immune cells: an emerging nanoscale vanguard in overcoming tumor immunotherapy hurdles
by: Xiaoyan Zhao, et al.
Published: (2025-08-01)